Transnetyx, a global leader in automated genotyping services, today announced the acquisition of BrainBits, a leading provider of fresh, micro-dissected brain and other tissues to the neuroscience, pharmacology and biotechnology research communities. The acquisition gives Transnetyx the ability to extend its product and service offerings to the university, hospital and bioscience researchers whom it serves throughout the world. By helping advance the BrainBits model, the acquisition also furthers the ability for Transnetyx to help reduce the number of animals used in science.